Gemcitabine in the chemoradiotherapy for locally advanced pancreatic cancer: A meta-analysis-Reference-Cited by-同舟云学术

Gemcitabine in the chemoradiotherapy for locally advanced pancreatic cancer: A meta-analysis

Published:2011-05 Issue:2 Volume:99 Page:108-113
ISSN:0167-8140
Container-title:Radiotherapy and Oncology
language:en
Short-container-title:Radiotherapy and Oncology

Author:

Zhu Chang-Peng,Shi Jian,Chen Yue-Xiang,Xie Wei-Fen,Lin Yong

Publisher

Elsevier BV

Subject

Radiology Nuclear Medicine and imaging,Oncology,Hematology

Reference57 articles.

1. Cancer statistics;Jemal;CA Cancer J Clin,2008

2. Pancreatic carcinoma;Rosewicz;Lancet,1997

3. Pancreatic cancer;Hidalgo;N Engl J Med,2010

4. Is there an optimal neoadjuvant therapy for locally advanced pancreatic cancer?;Kim;JOP,2007

5. Locally advanced pancreatic adenocarcinoma: where are we and where are we going? Highlights from the “2010 ASCO gastrointestinal cancers symposium”, Orlando, FL, USA, January 22–24, 2010;Richter;JOP,2010

Cited by 74 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effect of First-line Chemotherapy Alone Versus First-line Chemotherapy Plus Radiotherapy on Survival in Patients with Locally Advanced Pancreatic Cancer in the IMRT era: A Retrospective Cohort Study;2023-12-12

2. Perioperative and long-term survival outcomes of pancreatectomy with arterial resection in borderline resectable or locally advanced pancreatic cancer following neoadjuvant therapy: a systematic review and meta-analysis;International Journal of Surgery;2023-09-21

3. Current Approaches to the Management of Locally Advanced Pancreatic Cancer;Current Surgery Reports;2023-06-02

4. S3-Leitlinie zum exokrinen Pankreaskarzinom – Langversion 2.0 – Dezember 2021 – AWMF-Registernummer: 032/010OL;Zeitschrift für Gastroenterologie;2022-11

5. S3-Leitlinie zum exokrinen Pankreaskarzinom – Kurzversion 2.0 – Dezember 2021, AWMF-Registernummer: 032/010OL;Zeitschrift für Gastroenterologie;2022-06